Do irbesartan and amlodipine reduce cardiovascular events in diabetic patients?
When added to antihypertensive treatment in patients with diabetes and nephropathy, neither the angiotensin receptor blocker (ARB) irbesartan nor the calcium channel blocker amlodipine reduced the overall occurrence of cardiovascular events. However, irbesartan decreased the rate of heart failure and amlodipine reduced the rate of acute myocardial infarction.
Millard
Peter S
PS
Family Practice Residency Program, Eastern Maine Medical Center, Bangor, USA. pmillard@emh.org